KLF3 | Kruppel-like factor 3 (basic) | Transcription factors
| | | | | Expressed in all |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KLF5 | Kruppel-like factor 5 (intestinal) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KLF6 | Kruppel-like factor 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
KLF9 | Kruppel-like factor 9 | Transcription factors
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
L3MBTL1 | L(3)mbt-like 1 (Drosophila) | Transcription factors
| | | | | Mixed |
LYAR | Ly1 antibody reactive | Transcription factors
| | | | | Expressed in all |
MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MBD1 | Methyl-CpG binding domain protein 1 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MECOM | MDS1 and EVI1 complex locus | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MTA2 | Metastasis associated 1 family, member 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
MTA3 | Metastasis associated 1 family, member 3 | Plasma proteins Transcription factors
| | | | | Expressed in all |
MTF1 | Metal-regulatory transcription factor 1 | Transcription factors
| | | | | Expressed in all |
MYNN | Myoneurin | Transcription factors
| | | | | Expressed in all |
MYT1 | Myelin transcription factor 1 | Plasma proteins Transcription factors
| | | | | Group enriched |
MZF1 | Myeloid zinc finger 1 | Plasma proteins Transcription factors
| | | | | Expressed in all |
NR1H2 | Nuclear receptor subfamily 1, group H, member 2 | Cancer-related genes Nuclear receptors Transcription factors
| | | | | Expressed in all |
NR2C1 | Nuclear receptor subfamily 2, group C, member 1 | Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR2C2 | Nuclear receptor subfamily 2, group C, member 2 | Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | Nuclear receptors Transcription factors
| | | | | Expressed in all |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
PATZ1 | POZ (BTB) and AT hook containing zinc finger 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
PEG3 | Paternally expressed 3 | Transcription factors
| | | | | Tissue enhanced |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Group enriched |
PLAGL1 | Pleiomorphic adenoma gene-like 1 | Transcription factors
| | | | | Expressed in all |
POGZ | Pogo transposable element with ZNF domain | Plasma proteins Transcription factors
| | | | | Expressed in all |
PRDM1 | PR domain containing 1, with ZNF domain | Cancer-related genes Transcription factors
| | | | | Mixed |
PRDM2 | PR domain containing 2, with ZNF domain | Enzymes Transcription factors
| | | | | Expressed in all |
PRDM5 | PR domain containing 5 | Disease related genes Transcription factors
| | | | | Mixed |
RARA | Retinoic acid receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Mixed |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RC3H2 | Ring finger and CCCH-type domains 2 | Transcription factors
| | | | | Expressed in all |
REST | RE1-silencing transcription factor | Plasma proteins Transcription factors
| | | | | Expressed in all |
RLF | Rearranged L-myc fusion | Plasma proteins Transcription factors
| | | | | Expressed in all |
RORA | RAR-related orphan receptor A | Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RREB1 | Ras responsive element binding protein 1 | Transcription factors
| | | | | Expressed in all |
RXRA | Retinoid X receptor, alpha | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
RXRB | Retinoid X receptor, beta | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
SALL2 | Spalt-like transcription factor 2 | Transcription factors
| | | | | Mixed |
SALL4 | Spalt-like transcription factor 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
SNAI1 | Snail family zinc finger 1 | Transcription factors
| | | | | Tissue enhanced |
SNAI2 | Snail family zinc finger 2 | Disease related genes Transcription factors
| | | | | Mixed |
SP1 | Sp1 transcription factor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
SP2 | Sp2 transcription factor | Plasma proteins Transcription factors
| | | | | Expressed in all |